305 filings
Page 6 of 16
6-K
MDWD
MediWound Ltd
24 Jan 22
MediWound Announces Positive Topline Results From Its U.S. Phase 2 Trial of EscharEx for Debridement of Chronic Wounds
6:05am
6-K
MDWD
MediWound Ltd
20 Dec 21
MediWound Announces Positive Initial Data from its U.S. Phase 2 Pharmacology Study of
7:05am
6-K
MDWD
MediWound Ltd
6 Dec 21
MediWound Completes Enrollment of its EscharEx U.S. Phase 2 Adaptive Design Study
7:05am
6-K
MDWD
MediWound Ltd
16 Nov 21
MediWound Reports Third Quarter 2021 Financial Results
7:05am
6-K
MDWD
MediWound Ltd
10 Aug 21
MediWound Reports Second Quarter Financial Results
7:05am
6-K
MDWD
MediWound Ltd
28 Jul 21
MediWound Announces Positive Outcome of Interim Assessment for its
7:05am
6-K
MDWD
MediWound Ltd
26 Jul 21
MediWound Announces Initiation of U.S. Phase I/II Study of MW005 for the Treatment of Basal Cell Carcinoma
7:05am
6-K
MDWD
MediWound Ltd
20 Jul 21
MediWound Announces Positive Topline Results from Phase 3 Pediatric
7:05am
6-K
MDWD
MediWound Ltd
29 Jun 21
MediWound Receives Complete Response Letter from U.S. FDA for NexoBrid
8:54am
6-K
MDWD
MediWound Ltd
15 Jun 21
Current report (foreign)
4:06pm
6-K
MDWD
MediWound Ltd
5 May 21
Current report (foreign)
4:15pm
S-8
MDWD
MediWound Ltd
5 May 21
Registration of securities for employees
4:05pm
6-K
MDWD
MediWound Ltd
5 May 21
MediWound Reports First Quarter 2021 Financial Results
7:05am
6-K
MDWD
MediWound Ltd
22 Apr 21
Current report (foreign)
7:39am
424B3
MDWD
MediWound Ltd
22 Mar 21
Prospectus supplement
5:00pm
20-F
2020 FY
MDWD
MediWound Ltd
Annual report (foreign)
25 Feb 21
7:53am
6-K
MDWD
MediWound Ltd
25 Feb 21
MediWound Reports Fourth Quarter and Full-Year 2020 Financial Results
7:05am
6-K
MDWD
MediWound Ltd
22 Feb 21
MediWound Launches Clinical Development Program for Treatment of
6:30am
SC 13G
MDWD
MediWound Ltd
16 Feb 21
MediWound / Migdal Insurance & Financial ownership change
6:38am
SC 13G/A
MDWD
MediWound Ltd
2 Feb 21
MediWound / ROSENBERG LIOR ownership change
4:15pm